ERBB2 and breast cancer: Another study [65] examined the performance of DOX-loaded liposomes, functionalized with the monoclonal antibody Trastuzumab (TRA) for the enhanced targeting of breast cancer cells overexpressing the Human Epidermal growth factor Receptor 2 (HER2).